Where does Neurasignal, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neurasignal, Inc. ranks #20,138 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neurasignal, Inc. hold?

Neurasignal, Inc. holds 14 US utility patents granted between 2023 and 2025, spanning 13 technology areas.

What is Neurasignal, Inc.'s Innovation Score?

Neurasignal, Inc. has an Innovation Score of 53.2 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neurasignal, Inc. focus on?

Neurasignal, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 14 patents, ranking #1,252 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Neurasignal, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Neurasignal, Inc..

What does claim depth mean for Neurasignal, Inc.'s patents?

Neurasignal, Inc.'s patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neurasignal, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neurasignal, Inc.

USPTO PatentsView assignee record - 14 granted patents across 13 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurasignal ranks #20,138 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 13 technology areas.

#20,138
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.2/100): 18.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20138 · US Corporation #20,138 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 14 grants
MID-PACK #20,138/49,997
PHOTO-FINISH National Diversified…
CPC-FOCUS A61B · 13 areas
INNOV-PAR 53.2/100
CLAIMS-RICH 18.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: National Diversified Sales, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neurasignal’s 53.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (18%) Velocity 20.0 pts (38%) Breadth 12.7 pts (24%) Claim depth 11.1 pts (21%)

Qualcomm Incorporated · highest

85
Neurasignal · this assignee

53
3D Lighting… · lowest

7

What this shows Neurasignal's Innovation Score is 53.2/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neurasignal?

Each dot is one of Neurasignal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurasignal’s own 18.6 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neurasignal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neurasignal's grants concentrate

Neurasignal, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (7 grants) versus a trough of 2 in 2023. By volume, Neurasignal sits between National Diversified Sales, Inc. and NextgenID, Inc..

Neurasignal's three-year grant acceleration

Neurasignal, Inc. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

National Diversif…

14
Native Microbials

14
Neander Motors

14
Neuralight

14
New Power Concepts

14
New Standard Devi…

14
Next IT

14
Nextgenid

14
Neurasignal ◀

14

What this shows Neurasignal holds 14 patents at rank #20,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neurasignal

By rank, the assignees closest to #20,160 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Neurasignal's primary technology class.

Neurasignal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Neurasignal, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	14.3%
2024	7	50.0%
2025partial year	5	35.7%

Which technologies does Neurasignal, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 14

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A47C - CHAIRS; SOFAS; Beds 3

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

A47G - Household OR Table Equipment 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

A45D - Hairdressing OR Shaving Equipment ; Equipment FOR Cosmetics OR Cosmetic Treatments, e.g. FOR Manicuring OR Pedicuring 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

G06F - Electric Digital Data Processing 1

A42B - HATS; Head Coverings 1

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neurasignal, Inc.'s patent record in context - here's where to go next.

Neurasignal, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #20,138 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neurasignal, Inc. against National Diversified Sales, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.